Menthozen Cream

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Menthozen Cream
Generic name: METHYL SALICYLATE, MENTHOL, CAPSAICIN
Manufacturer: Proficient Rx LP
Product type: HUMAN OTC DRUG
SPL set ID: 66681906-c5f5-4c57-bb43-9c83cccc0062
SPL ID: 40b3d1f4-5e9c-4a4f-a2da-b30dc0cb8c12
Version: 2
Effective date: 2023-12-01
Source export date: 2026-09-28
Source partition: 11
Source file: https://download.open.fda.gov/drug/label/drug-label-0011-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/aa96b5a2be6b394393acd0090f6948bdf99e0e8e00666f81608929c8fa83db77/drug-label-0011-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 06:18:07

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 13 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M017	openfda.application_number
brand name		Menthozen Cream	openfda.brand_name
generic name		METHYL SALICYLATE, MENTHOL, CAPSAICIN	openfda.generic_name
manufacturer name		Proficient Rx LP	openfda.manufacturer_name
ndc	package	71205-771-72	openfda.package_ndc
ndc	product	71205-771	openfda.product_ndc
ndc11	package	71205077172	derived:openfda.package_ndc
rxcui		1099896	openfda.rxcui
spl id		40b3d1f4-5e9c-4a4f-a2da-b30dc0cb8c12	id
spl set id		66681906-c5f5-4c57-bb43-9c83cccc0062	set_id
unii		S07O44R1ZM	openfda.unii
unii		L7T10EIP3A	openfda.unii
unii		LAV5U5022Y	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

WARNINGS: • For external use only. • Avoid contact with the eyes. • If condition worsens, or if symptoms persist for more than seven days or clear up and occur again with a few days, discontinue use of this product and consult a physician. Keep out of reach of children. • If swallowed, consult physician • Do not apply to wounds or damaged skin. • Do not bandage tightly. If pregnant or breast feeding, contact a physician prior to use.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.